GHANSHYAM TECH ANALYSIS
02 June 2023 04:32
Auto Stocks of companies like Tata Motors, TVS Motor and Hero MotoCorp will be in focus on May sales numbers.
Info Edge
The company on Thursday, said its wholly owned subsidiary Allcheckdeals India Private Ltd's (AIPL) loan of Rs 280 crore to 4B Networks is fully impaired. AIPL is initiating a forensic audit into the affairs of 4B Networks and has appointed Deloitte Touche Tohmatsu India LLP as the forensic auditor to probe the matter and will be supported and assisted by Saraf and Partners Law Offices, legal advisors to the company
NHPC
State-owned hydro power giant on Thursday inked an initial pact with Nepalese utility Vidhyut Utpadan Company for developing a 480 MW Phukot Karnali hydroelectric project.
Paras Defence
The company on Thursday said it has entered into a joint venture agreement with CONTROP Precision Technologies Ltd, Israel, with the purpose of undertaking business of manufacturing, implementation of Integrated Logistics Support after sale support, training, etc, in the electro-optic or infra-red systems
Bank of Maharashtra
The Pune-based state-run lender launched a Qualified Institutional Placement (QIP) issue on Thursday, June 1 to raise funds from institutional investors. The floor price of the issue has been fixed at Rs 29.98 per share, a discount of five percent from it's previous closing price.
Aditya Birla Capital
The company on Thursday said its board has approved preferential issuance of Rs 1,250 crore to its promoter and promoter group entity at Rs 165 per share. Of the Rs 1,250 crore fundraising, Grasim will be issued Rs 1,000 crore shares and Surya Kiran Investments Rs 250 crore.
AstraZeneca
The pharma major received the nod from the Central Drugs Standard Control Organisation, Directorate General of Health Services, to import tremelimumab (Imjudo) concentrate. It is used for certain type of liver tumour.
Adani Enterprises
Adani Road Transport, a wholly-owned subsidiary of the company, has decided to terminate the pact to purchase Macquarie Asia Infrastructure Fund's toll road portfolio in Andhra Pradesh and Gujarat for Rs 3,110 crore. Additionally, the National Stock Exchange (NSE) and BSE have removed the securities of Adani Enterprises from the short-term ASM framework.
Dish TV
Direct-to-home operator informed that the notice issued by Vis Legis Law Practice on behalf of minority shareholders for holding an extraordinary general meeting of the company is invalid. This comes after a group of minority shareholders of Dish TV send a notice to call an EGM of the company, raising concerns over corporate governance issues, seeking reconstitution of the board and removal of two independent directors questioning their independence
Aster DM Healthcare
Healthcare services provider entered into a hospital operation and management agreement with Padmavathy Medical Foundation (PMF). PMF is a 130-bed tertiary super specialty hospital situated in Sasthamkotta, Kollam District, Kerala.
Читать полностью…
GHANSHYAM TECH ANALYSIS
02 June 2023 04:31
1 June 23
FII & DII DATA
FII Net SELL - 71.07cr
DII Net BUY - 488.93cr
Читать полностью…
GHANSHYAM TECH ANALYSIS
02 June 2023 04:31
नमस्कार दोस्तों - यह चैनल स्टॉक मार्किट लर्निंग के लिए बनाया गया है इस चैनल पर दिए हुए पोस्ट आप को सीखने के लिए दिए जाते है अगर आप सिखने में दिलचस्पी रखते तो ही इस चैनल से जुड़े , अगर आप दिए हुआ लेवल पर ट्रेड करते है तो आप अपनी रिसर्च ये आपने फाइनेंसियल एडवाइजर से सलाह मस्वारा जरूर कर ले -
स्टॉक मार्किट में बिना नॉलेज के ट्रेड करने आप को मुश्किल में डाल सकता है इस लिए किसे के बहकावे में मत आये इस लिए सीखे , समझे और फिर स्टॉक में आये और कभी ही अपने सेविंग का १० % से ज्यादा यहाँ इन्वेस्टमेंट न करे
ये सभी बातो का आप पालन करते है तभी हमारे चैनल को ज्वाइन करे
- धन्यवाद
Читать полностью…
GHANSHYAM TECH ANALYSIS
01 June 2023 14:47
Option Seller कब डरता है Part-2 !! इसके बाद OPTION BUYER का Profit Rocket से भी तेज बनता है
https://youtu.be/gSCTMIOp6qg
Читать полностью…
GHANSHYAM TECH ANALYSIS
01 June 2023 08:50
bank nifty test your patience
Читать полностью…
GHANSHYAM TECH ANALYSIS
01 June 2023 04:32
Adani Group
Billionaire Gautam Adani’s conglomerate is looking to raise about $3 billion through an equity share sale to institutional investors in the boldest comeback strategy after the ports-to-energy group was hit by a damning report of a US short seller. While boards of Adani Enterprises and Adani Transmission have already approved raising up to Rs 21,000 crore through share sales to qualified institutional investors, the board of Adani Green Energy is likely to do so for raising up to $1 billion in the next couple of weeks.
Laurus Labs
Drug firm on Wednesday said the company is acquiring an additional 7.24 percent stake in Immunoadoptive Cell Therapy (ImmunoACT) Private Ltd for Rs 80 crore. Post the completion of the deal, Laurus Labs’ stake in ImmunoACT will increase to 33.86 percent (on a fully diluted basis), the company said in an exchange filing.
Rainbow Children’s Medicare
R Gowrisankar resigned as the CFO of the company with effect from May 31, 2023. The company has appointed Vikas Maheshwari As CFO Of The the company w.e.f. June 1, 2023.
South Indian Bank
Private lender on Wednesday said it has finalised the names of candidates for the post of managing director (MD) and chief executive officer (CEO). Also, it said the board of directors of the bank has today (May 31) approved the panel of candidates, in order of preference, for the position of the managing director and chief executive officer of the bank.
Coal India
The central government will sell a stake in India's largest coal miner Coal India Ltd (CIL) through an offer for sale (OFS) on the BSE and NSE on Thursday (June 1), sources told CNBC-TV18 on May 31. The size of OFS is likely to be around Rs 4,000 crore. The OFS will open tomorrow for non-retail investors. Retail investors can bid on Friday.
Gati
Logistics services provider on Wednesday said CEO Pirojshaw Aspi Sarkari has stepped down from the position with immediate effect from today. Also, Gati has appointed Pirojshaw Aspi Sarkari as the managing director and chief executive officer of the material subsidiary of the company, Gati-Kintetsu Express Private Ltd (GKEPL) with immediate effect from May 31.
Читать полностью…
GHANSHYAM TECH ANALYSIS
01 June 2023 04:31
कृपया ध्यान दे हमारी कोई Paid Service ,Paid Training & Paid Group नहीं है तो जो हमारे नाम से आप से पैसे माँगते है वो सभी Fraud है तो उन चोरो से आप सावधान रहे मुझे सिर्फ आप लोगो का आशीर्वाद चाहिए - धन्यवाद
Читать полностью…
GHANSHYAM TECH ANALYSIS
31 May 2023 17:02
Super Profitable Candlestick Chart Pattern - 11 !! ये Candle डरे हुए Buyer को बहादुर बना देती है
https://youtu.be/BYguSwO6dPc
Читать полностью…
GHANSHYAM TECH ANALYSIS
31 May 2023 11:58
कृपया ध्यान दे हमारी कोई Paid Service ,Paid Training & Paid Group नहीं है तो जो हमारे नाम से आप से पैसे माँगते है वो सभी Fraud है तो उन चोरो से आप सावधान रहे मुझे सिर्फ आप लोगो का आशीर्वाद चाहिए - धन्यवाद
Читать полностью…
GHANSHYAM TECH ANALYSIS
31 May 2023 11:58
➡️Open your Demat Account in UPSTOX - https://upstox.com/open-account/?f=FC2757
Читать полностью…
GHANSHYAM TECH ANALYSIS
31 May 2023 11:58
➡️Open your Demat Account in ZERODHA - https://zerodha.com/open-account?c=ZMPCFT
Читать полностью…
GHANSHYAM TECH ANALYSIS
31 May 2023 07:40
Just view Bank nifty 44177 key point
Читать полностью…
GHANSHYAM TECH ANALYSIS
31 May 2023 04:32
HDFC Life Insurance Company
UK-based investment company Abrdn is likely to sell a 1.66 percent (3.57 crore shares) stake in HDFC Life Insurance Company Ltd via block deals on Wednesday (May 31), sources told CNBC-TV18. The Edinburgh-based company, which was formerly known as Standard Life Aberdeen, has offered the shares in the price band of Rs 563.20-585.15, said sources. BofA Securities India Ltd is the sole book runner for the sale of shares, they added.
Mazagon Dock Shipbuilders
The company clocked strong earnings in the fourth quarter of the financial year 2022-23. Revenues are 49 percent higher at Rs 2,078 crore. Earnings before interest, tax, depreciation and amortisation (EBITDA) nearly tripled to Rs 211 crore versus Rs 77 crore year on year. EBITDA margins doubled to 10.1 percent versus 5.5 percent in the corresponding quarter of last year
Torrent Pharmaceuticals
Drug firm on Tuesday reported a net profit of Rs 287 crore for the fourth quarter that ended March 31, 2023. In the corresponding quarter last year, the company posted a net loss of Rs 118 crore. In the March quarter, total revenue stood at Rs 2,491 crore, up 16.9 percent against Rs 2,131 crore in the corresponding period of the preceding fiscal.
Adani Ports and Special Economic Zone
The company on Tuesday posted a 5.1 percent year-on-year increase in consolidated net profit at Rs 1,158.9 crore for the fourth quarter that ended March 31, 2023. In the March quarter, total revenue stood at Rs 5,797 crore, up 40 percent against Rs 4,140.8 crore in the corresponding period of the preceding fiscal.
Sona BLW
Promoter entity Aureus Investment Private Ltd is likely to sell up to a 3.25 percent stake in automotive technology firm Sona BLW Precision Forgings (Sona Comstar) via a block deal on Wednesday (May 31), sources privy to the developments told CNBC-TV18. The base size of the block deal is likely to be Rs 600 crore, with a green shoe option of Rs 350 crore. The total deal size is Rs 950 crore including the green shoe option, sources close to the development said.
Patanjali Foods
The company on Tuesday reported a 12.49 percent year-on-year jump in net profit at Rs 263.71 crore for the fourth quarter that ended March 31, 2023. In the March quarter, total revenue stood at Rs 7,872.92 crore during the period under review, up 18.15 percent against Rs 6,663.72 crore in the corresponding period of the preceding fiscal.
Coal India
The board of Coal India Ltd on Tuesday approved an eight percent increase in the prices of high-grade coal ranging from G2 to G10. This price hike will be applicable to all subsidiaries of Coal India Limited, which is expected to result in significant incremental revenue for the company. The approved price hike is anticipated to generate approximately Rs 2,703 crore of incremental revenue for the balance period of FY24.
Lupin
Drug maker on Tuesday said it has inked a strategic pact with Enzene Biosciences to launch cetuximab in India, the first biosimilar developed for intravenous infusion. In July 2009, the US Food and Drug Administration (USFDA) approved cetuximab (Erbitux) for the treatment of a type of colon cancer.
Читать полностью…
487008